[
  {
    "ts": null,
    "headline": "Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial",
    "summary": "We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Merck & Co., Inc. (NYSE:MRK) is one of the top performers on Tuesday. Shares of Merck & Co. Inc. (NYSE:MRK) rallied for a third straight day on Tuesday, as investors snapped up shares on twin catalysts, including tariffs on pharmaceutical imports and stellar results […]",
    "url": "https://finnhub.io/api/news?id=81c5d49b0691c406f15f2a0e2e7165947775ebe4e7f20ea6e9ef733e3ca233b0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759354565,
      "headline": "Merck (MRK) Jumps 6.8% on Trump Tariffs, Stellar Pulmonary Hypertension Drug Trial",
      "id": 136952239,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Merck & Co., Inc. (NYSE:MRK) is one of the top performers on Tuesday. Shares of Merck & Co. Inc. (NYSE:MRK) rallied for a third straight day on Tuesday, as investors snapped up shares on twin catalysts, including tariffs on pharmaceutical imports and stellar results […]",
      "url": "https://finnhub.io/api/news?id=81c5d49b0691c406f15f2a0e2e7165947775ebe4e7f20ea6e9ef733e3ca233b0"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
    "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
    "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352755,
      "headline": "S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown",
      "id": 136951001,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The S&P 500 and the Dow Jones Industrial Average hit new record highs on Wednesday as traders appear",
      "url": "https://finnhub.io/api/news?id=46463ae646d7ca61aa8571ec1d7bcf123f5787c7df74df4a1cce9896692a2f53"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
    "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
    "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352100,
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "id": 136952143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls",
    "summary": "US equity indexes rose at the close on Wednesday amid gains in healthcare and increasing bets favori",
    "url": "https://finnhub.io/api/news?id=2773ac517cad9f7334b97c8ca3bc6e16ed94b3b558af0a0f32ccb9433f36b485",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759351970,
      "headline": "US Equity Indexes Rise as Healthcare Jumps, October Rate-Cut Certainty Increases Amid Surprise Fall in Private Payrolls",
      "id": 136952242,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "US equity indexes rose at the close on Wednesday amid gains in healthcare and increasing bets favori",
      "url": "https://finnhub.io/api/news?id=2773ac517cad9f7334b97c8ca3bc6e16ed94b3b558af0a0f32ccb9433f36b485"
    }
  },
  {
    "ts": null,
    "headline": "Why Merck (MRK) Stock Is Up Today",
    "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
    "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348850,
      "headline": "Why Merck (MRK) Stock Is Up Today",
      "id": 136951004,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 7.7% in the afternoon session after the Trump administration announced a new program to sell drugs directly to consumers.",
      "url": "https://finnhub.io/api/news?id=486fce15972b9fed8e3956ff090de0e7fa1db96758b3a92330e210d6b93ed58a"
    }
  },
  {
    "ts": null,
    "headline": "Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins",
    "summary": "US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an",
    "url": "https://finnhub.io/api/news?id=26f967bc0e65373ca871110fb9a6f5a71e2f2cb3b47c5951634e8317d6bd24b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759348643,
      "headline": "Healthcare Helps Lift US Equity Indexes After Federal Shutdown Begins",
      "id": 136952244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "US equity indexes rose ahead of the close on Wednesday amid strong gains in the healthcare sector an",
      "url": "https://finnhub.io/api/news?id=26f967bc0e65373ca871110fb9a6f5a71e2f2cb3b47c5951634e8317d6bd24b4"
    }
  },
  {
    "ts": null,
    "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
    "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
    "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759343791,
      "headline": "Equities Rise Intraday as Markets Look Past Shutdown",
      "id": 136951005,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "US benchmark equity indexes rose intraday as traders appeared to look past a federal government shut",
      "url": "https://finnhub.io/api/news?id=086767a9660837a406fab452a5b0cc67fe4dd2e002f497725a26a124b909e4f7"
    }
  },
  {
    "ts": null,
    "headline": "US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins",
    "summary": "US equity indexes were mixed in midday trading on Wednesday as healthcare helped offset losses, whil",
    "url": "https://finnhub.io/api/news?id=61675de07f152141193b70daa10b4e4341d46e83bbed41139e9ff6a4533b822a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759340871,
      "headline": "US Equity Indexes Mixed Amid Healthcare Gains While Treasury Yields Drop as Partial Shutdown Begins",
      "id": 136952246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "US equity indexes were mixed in midday trading on Wednesday as healthcare helped offset losses, whil",
      "url": "https://finnhub.io/api/news?id=61675de07f152141193b70daa10b4e4341d46e83bbed41139e9ff6a4533b822a"
    }
  },
  {
    "ts": null,
    "headline": "OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1",
    "summary": "We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations spanning diagnostics, pharmaceuticals, and innovative therapies. Its business is anchored by BioReference Laboratories and a growing pipeline focused on immuno-oncology, immune rejuvenation, […]",
    "url": "https://finnhub.io/api/news?id=9c51d7fd4e2920a7b0f30d55a057e9503fe70af5a0287044cb17b6df57654568",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759340698,
      "headline": "OPKO Health, Inc. (OPK)’s ModeX Division Pushes Four Immuno-Oncology Candidates into Phase 1",
      "id": 136952247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. OPKO Health, Inc. is one of them. OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company with operations spanning diagnostics, pharmaceuticals, and innovative therapies. Its business is anchored by BioReference Laboratories and a growing pipeline focused on immuno-oncology, immune rejuvenation, […]",
      "url": "https://finnhub.io/api/news?id=9c51d7fd4e2920a7b0f30d55a057e9503fe70af5a0287044cb17b6df57654568"
    }
  },
  {
    "ts": null,
    "headline": "Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks",
    "summary": "Yahoo Finance anchor Julie Hyman outlines some of the biggest stories as part of this Market Minute, including pharmaceutical stocks rising on Pfizer's (PFE) tariff deal with the Trump administration, Reddit (RDDT) stock sinking as new data shows that the number of ChatGPT's (OPAI.PVT) responses referencing Reddit content has declined, and Jefferies' bullish Sunrun (RUN) call. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
    "url": "https://finnhub.io/api/news?id=924ce6709fdd7f3299136f8a717717617a9b0625410a2b15fe550f29c27bdb05",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759335450,
      "headline": "Reddit sinks on ChatGPT data, Pfizer deal boosts pharma stocks",
      "id": 136947202,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Yahoo Finance anchor Julie Hyman outlines some of the biggest stories as part of this Market Minute, including pharmaceutical stocks rising on Pfizer's (PFE) tariff deal with the Trump administration, Reddit (RDDT) stock sinking as new data shows that the number of ChatGPT's (OPAI.PVT) responses referencing Reddit content has declined, and Jefferies' bullish Sunrun (RUN) call. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.",
      "url": "https://finnhub.io/api/news?id=924ce6709fdd7f3299136f8a717717617a9b0625410a2b15fe550f29c27bdb05"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Stock, Other Drugmakers Rally Again",
    "summary": "After its best day in nearly four years Tuesday, Pfizer stock is giving an encore performance. Shares of the drugmaker are up 5.5% in midday trading as investors digest yesterday's news that Pfizer would get a three-year exemption from national-security-related tariffs, in return for domestic manufacturing investments and Pfizer's participation in a government-run website called TrumpRx.",
    "url": "https://finnhub.io/api/news?id=3d4f225276ac87a5c85b10c4e7ba33633e09007d4b366cd4c04200e8c17b96b4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759333445,
      "headline": "Pfizer Stock, Other Drugmakers Rally Again",
      "id": 136947203,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "After its best day in nearly four years Tuesday, Pfizer stock is giving an encore performance. Shares of the drugmaker are up 5.5% in midday trading as investors digest yesterday's news that Pfizer would get a three-year exemption from national-security-related tariffs, in return for domestic manufacturing investments and Pfizer's participation in a government-run website called TrumpRx.",
      "url": "https://finnhub.io/api/news?id=3d4f225276ac87a5c85b10c4e7ba33633e09007d4b366cd4c04200e8c17b96b4"
    }
  },
  {
    "ts": null,
    "headline": "Q: Will TrumpRx and ‘Most Favored Nation’ Deals Save Americans Money?",
    "summary": "A: Pfizer is the first drugmaker to reach an agreement with the White House that includes selling its drugs to Medicaid at the lowest price available to other developed countries, the “most-favored-nation” price.  Most Americans enrolled in health plans will likely save more money using their insurance.  For Medicaid patients, it is unclear whether the “most favored nation” pricing will be lower than what the program currently pays.",
    "url": "https://finnhub.io/api/news?id=f87470901d1b48e64f742dd1c75e88cf230248dcd282d7a633a839623e87d40c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759330997,
      "headline": "Q: Will TrumpRx and ‘Most Favored Nation’ Deals Save Americans Money?",
      "id": 136947204,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "A: Pfizer is the first drugmaker to reach an agreement with the White House that includes selling its drugs to Medicaid at the lowest price available to other developed countries, the “most-favored-nation” price.  Most Americans enrolled in health plans will likely save more money using their insurance.  For Medicaid patients, it is unclear whether the “most favored nation” pricing will be lower than what the program currently pays.",
      "url": "https://finnhub.io/api/news?id=f87470901d1b48e64f742dd1c75e88cf230248dcd282d7a633a839623e87d40c"
    }
  },
  {
    "ts": null,
    "headline": "Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym?",
    "summary": "Corcept expects relacorilant to ease sole reliance on Korlym for revenues. Relacorilant is under FDA review for Cushing's syndrome and ovarian cancer.",
    "url": "https://finnhub.io/api/news?id=0752f1ecada87e299e442c2a0236f7fd4018e92065e8d177e1c84c581bb400b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759329600,
      "headline": "Can Relacorilant Drive Corcept's Long-Term Growth Beyond Korlym?",
      "id": 136947331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Corcept expects relacorilant to ease sole reliance on Korlym for revenues. Relacorilant is under FDA review for Cushing's syndrome and ovarian cancer.",
      "url": "https://finnhub.io/api/news?id=0752f1ecada87e299e442c2a0236f7fd4018e92065e8d177e1c84c581bb400b3"
    }
  },
  {
    "ts": null,
    "headline": "Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental",
    "summary": "↗️ Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.",
    "url": "https://finnhub.io/api/news?id=0c07d91dfc9d3e0294361190c520161e7d11d3f8d6816c7d27813c5f3214b964",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759309518,
      "headline": "Stocks to Watch Wednesday: Nike, Lithium Americas, Arm, Occidental",
      "id": 136944164,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "↗️ Lithium Americas (LAC): The U.S. government said Tuesday it would take a 5% stake in both the Canadian company and its Nevada mining project. Shares jumped by roughly one-third in premarket trading.",
      "url": "https://finnhub.io/api/news?id=0c07d91dfc9d3e0294361190c520161e7d11d3f8d6816c7d27813c5f3214b964"
    }
  },
  {
    "ts": null,
    "headline": "Top 10 High-Yield Dividend Stocks For October 2025",
    "summary": "Discover October 2025âs top 10 high-yield dividend stocks with a 3.95% avg. yield & 19.02% projected return. Click for the picks!",
    "url": "https://finnhub.io/api/news?id=83d57c0c12f34339bb98d78e6eda673278ead69358637ae98d03a55899b752f0",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759328602,
      "headline": "Top 10 High-Yield Dividend Stocks For October 2025",
      "id": 136948703,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2235939814/image_2235939814.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Discover October 2025âs top 10 high-yield dividend stocks with a 3.95% avg. yield & 19.02% projected return. Click for the picks!",
      "url": "https://finnhub.io/api/news?id=83d57c0c12f34339bb98d78e6eda673278ead69358637ae98d03a55899b752f0"
    }
  },
  {
    "ts": null,
    "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
    "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
    "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759325460,
      "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
      "id": 136947247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
      "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1"
    }
  },
  {
    "ts": null,
    "headline": "European healthcare stocks surge after US deal with Pfizer",
    "summary": "STORY: European healthcare stocks jumped on Wednesday, mirroring moves in the United States.It comes a day after U.S.-based drugmaker Pfizer and President Donald Trump announced an agreement to lower prescription drug prices in the Medicaid program in exchange for tariff relief.Healthcare stocks in the U.S. and Europe have been lagging this year as a result of uncertainty about the Trump administration's stance on drug pricing.Analysts said the Pfizer deal had reduced uncertainty for the sector.Trump sent letters to 17 leading drug companies in July telling them to slash prices to match those paid overseas.Pfizer is the first to announce a deal.Europe's healthcare sector index rose 2.77%, which if sustained would be its biggest daily percentage gain since April.AstraZeneca, Ambu, Merck and Sartorius were among those to climb.Pfizer shares rose 7% on Tuesday, and other U.S. pharma stocks also gained.",
    "url": "https://finnhub.io/api/news?id=e1362238af10635517926371f8ccb72fe98564dab92da9c050e5389996232440",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320399,
      "headline": "European healthcare stocks surge after US deal with Pfizer",
      "id": 136945743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "STORY: European healthcare stocks jumped on Wednesday, mirroring moves in the United States.It comes a day after U.S.-based drugmaker Pfizer and President Donald Trump announced an agreement to lower prescription drug prices in the Medicaid program in exchange for tariff relief.Healthcare stocks in the U.S. and Europe have been lagging this year as a result of uncertainty about the Trump administration's stance on drug pricing.Analysts said the Pfizer deal had reduced uncertainty for the sector.Trump sent letters to 17 leading drug companies in July telling them to slash prices to match those paid overseas.Pfizer is the first to announce a deal.Europe's healthcare sector index rose 2.77%, which if sustained would be its biggest daily percentage gain since April.AstraZeneca, Ambu, Merck and Sartorius were among those to climb.Pfizer shares rose 7% on Tuesday, and other U.S. pharma stocks also gained.",
      "url": "https://finnhub.io/api/news?id=e1362238af10635517926371f8ccb72fe98564dab92da9c050e5389996232440"
    }
  },
  {
    "ts": null,
    "headline": "Big Pharma's big boost: Market Movers",
    "summary": "Pharma giants in the US had a massive boost after Pfizer (PFE) avoided tariffs by coming to an agreement with Donald Trump to sell drugs directly to the American people at a lower price. Domestic competitors Eli Lilly (LLY) and Merck (MRK) are expected to follow suit, as Pfizer also announced $70 billion dollars worth of investment in the US. The ripple effects were also felt in Europe and beyond. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.",
    "url": "https://finnhub.io/api/news?id=1ce3ee5a61ff50b2d2825bb52f238f67de975bb396f5471aa4a46561797f862a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320182,
      "headline": "Big Pharma's big boost: Market Movers",
      "id": 136947207,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Pharma giants in the US had a massive boost after Pfizer (PFE) avoided tariffs by coming to an agreement with Donald Trump to sell drugs directly to the American people at a lower price. Domestic competitors Eli Lilly (LLY) and Merck (MRK) are expected to follow suit, as Pfizer also announced $70 billion dollars worth of investment in the US. The ripple effects were also felt in Europe and beyond. For more live coverage of markets watch the full episode of Market Sunrise and head to Yahoo Finance.",
      "url": "https://finnhub.io/api/news?id=1ce3ee5a61ff50b2d2825bb52f238f67de975bb396f5471aa4a46561797f862a"
    }
  },
  {
    "ts": null,
    "headline": "How Fifth Third Bancorp, Merck, And Duke Energy Can Put Cash In Your Pocket",
    "summary": "Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Fifth Third Bancorp, Merck, and Duke Energy have rewarded shareholders for years and recently announced dividend increases. ...",
    "url": "https://finnhub.io/api/news?id=d7bf3ebbb9656da8a57d2960727308d9aa7b1fd8b75bc71687926be15790219a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759320062,
      "headline": "How Fifth Third Bancorp, Merck, And Duke Energy Can Put Cash In Your Pocket",
      "id": 136944605,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors. Fifth Third Bancorp, Merck, and Duke Energy have rewarded shareholders for years and recently announced dividend increases. ...",
      "url": "https://finnhub.io/api/news?id=d7bf3ebbb9656da8a57d2960727308d9aa7b1fd8b75bc71687926be15790219a"
    }
  },
  {
    "ts": null,
    "headline": "Amgen, Merck share gains lead Dow's 119-point jump",
    "summary": "Amgen, Merck share gains lead Dow's 119-point jump",
    "url": "https://finnhub.io/api/news?id=75527ed925ad7bfc9fca5a9f79566e76ec24ffde4704eebc3262e39a9f8e0ed7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759319100,
      "headline": "Amgen, Merck share gains lead Dow's 119-point jump",
      "id": 136996409,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Amgen, Merck share gains lead Dow's 119-point jump",
      "url": "https://finnhub.io/api/news?id=75527ed925ad7bfc9fca5a9f79566e76ec24ffde4704eebc3262e39a9f8e0ed7"
    }
  },
  {
    "ts": null,
    "headline": "Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30",
    "summary": "RAHWAY, N.J., October 01, 2025--Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30",
    "url": "https://finnhub.io/api/news?id=88e9446e1984967bb60c289bb98562d8d69a3535f3c01ed26b6291e4d5c920ea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759315500,
      "headline": "Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30",
      "id": 136944140,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., October 01, 2025--Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30",
      "url": "https://finnhub.io/api/news?id=88e9446e1984967bb60c289bb98562d8d69a3535f3c01ed26b6291e4d5c920ea"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot",
    "summary": "A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.",
    "url": "https://finnhub.io/api/news?id=00f49db858a494509b37a7effcd3109370829982f3875184f265e9fd35b2747e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759314600,
      "headline": "Pfizer’s Drug Price Deal with White House Gives Big Pharma a Booster Shot",
      "id": 136952151,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "A 2024 RAND study found that US drug prices are 278% higher than in 33 other developed countries in the OECD.",
      "url": "https://finnhub.io/api/news?id=00f49db858a494509b37a7effcd3109370829982f3875184f265e9fd35b2747e"
    }
  },
  {
    "ts": null,
    "headline": "Convatec to open new R&D hub in Manchester as part of £500m UK investment",
    "summary": "The medical products firm said the ‘flagship’ site would open in 2027.",
    "url": "https://finnhub.io/api/news?id=a91e5ca6a0c231107ec195d5eab35e4d19205a3b0c84c97ca0e52f328277d2fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759310434,
      "headline": "Convatec to open new R&D hub in Manchester as part of £500m UK investment",
      "id": 136944141,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "The medical products firm said the ‘flagship’ site would open in 2027.",
      "url": "https://finnhub.io/api/news?id=a91e5ca6a0c231107ec195d5eab35e4d19205a3b0c84c97ca0e52f328277d2fa"
    }
  }
]